Search Results - "Engineer R"

Calculator program aids sucker-rod systems design and optimization.

Authors: Engineer, R.

Source: Oil & Gas Journal; August 15 1983, Vol. 81, p56-63, 8p

Computed Tomography-Based Interstitial Brachytherapy for Recurrent Cervical Carcinoma in the Vaginal Apex.

Authors: Engineer, R. Chopra, S. Shukla, R. et al.

Source: Clinical Oncology. Jan2022, Vol. 34 Issue 1, pe1-e6. 6p.

From two-dimensional to three-dimensional conformal radiotherapy in prostate cancer: An Indian experience.

Authors: Engineer, R. Bhutani, R. Mahantshetty, U. et al.

Source: Indian Journal of Cancer. Jul-Sep2010, Vol. 47 Issue 3, p332-338. 7p. 5 Charts, 3 Graphs.

Matched Pair Analysis of Locally Advanced Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy (MAPLAP).

Authors: Peddi, M. Engineer, R. Bhandare, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pe478-e479. 2p.

Subjects: Neoadjuvant chemotherapy, Propensity score matching, Stereotactic radiotherapy, Age groups, Progression-free survival

Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy.

Authors: Engineer, R. Pathare, P. Bhandare, M. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2024 Supplement, Vol. 120 Issue 2, pe437-e438. 2p.

Subjects: Neoadjuvant chemotherapy, Pancreatic cancer, Overall survival, Surgical complications, Cancer patients

PO-1251 Upfront surgery vs. neoadjuvant chemoradiation in upper rectal cancers.

Authors: Engineer, R. Poddar, J. Pandey, D. et al.

Source: Radiotherapy & Oncology. 2021 Supplement 1, Vol. 161, pS1031-S1033. 3p.

Subjects: Rectal cancer, Chemoradiotherapy, Surgery

Persistent involvement of anterior mesorectal fascia in carcinoma rectum – extended resection of rectum vs total pelvic exenteration: results from a single‐centre retrospective study.

Authors: Verma, K. Engineer, R. Ostwal, V. et al.

Source: Colorectal Disease. Dec2018, Vol. 20 Issue 12, p1070-1077. 8p.

High nodal positivity rates even in good clinical responders after chemoradiation of rectal cancer: is organ preservation feasible?

Authors: Vallam, K. C. Engineer, R. Desouza, A. et al.

Source: Colorectal Disease. Oct2016, Vol. 18 Issue 10, p976-982. 7p.

Dose Escalation Using Magnetic Resonance Guided High-Dose-Rate Endorectal Brachytherapy to Enhance Clinical Response after Neoadjuvant Radiotherapy in Rectal Adenocarcinoma.

Authors: Engineer, R. Datta, D. Gudi, S. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2023 Supplement, Vol. 117 Issue 2, pe295-e295. 1p.

Subjects: Rectal cancer, High dose rate brachytherapy, Magnetic resonance, Radioisotope brachytherapy, Surgical stomas, Preservation of organs, tissues, etc., Adenocarcinoma

PO-1318 MRI based radiomics as imaging biomarker for response to Neoadjuvant Chemoradiation in Rectal Cancer.

Authors: Puppalwar, A. Engineer, R. Kumar, S. et al.

Source: Radiotherapy & Oncology. 2022 Supplement 1, Vol. 170, pS1113-S1114. 2p.

Subjects: Rectal cancer, Radiomics, Chemoradiotherapy, Magnetic resonance imaging, Biomarkers

OC-0632 Endorectal brachytherapy to enhance complete response receiving neoadjuvant CTRT in rectal cancers.

Authors: Engineer, R. Dutta, D. Saklani, A. et al.

Source: Radiotherapy & Oncology. 2022 Supplement 1, Vol. 170, pS562-S563. 2p.

Subjects: Rectal cancer, Radioisotope brachytherapy

Reduction of Tumor Length by >50%, Post Neoadjuvant Chemoradiation as a Predictor for Complete Response and Organ Preservation in Rectal Cancer.

Authors: Engineer, R. Datta, D. Saklani, A. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2022 Supplement, Vol. 114 Issue 3, pe157-e157. 1p.

Subjects: Rectal cancer, Preservation of organs, tissues, etc., High dose rate brachytherapy, Patient selection, Chemoradiotherapy

PO-1210 Is SBRT safe in carcinoma pancreas having duodenal infiltration?

Authors: Engineer, R. Poddar, J. Anoop, A. et al.

Source: Radiotherapy & Oncology. 2021 Supplement 1, Vol. 161, pS1003-S1003. 1p.

Subjects: Pancreas, Carcinoma

Stereotactic Body Radiation Therapy Post Induction Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.

Authors: Engineer, R. Lewis, S.C. Ostwal, V. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pe71-e72. 2p.

Feasibility of Wait and Watch Approach after Neoadjuvant Chemoradiotherapy in Rectal Cancer in Low- and Middle-Income Countries: Initial Experience in Tertiary Cancer Centre in India.

Authors: Patil, M.B. Engineer, R. Lewis, S.C. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pe15-e16. 2p.

OC-0508 MRI guided chemoradiation and brachytherapy for postsurgical vaginal recurrences: A phase II study.

Authors: Chopra, S. Engineer, R. Mahantshetty, U. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS263-S264. 2p.

Subjects: Radioisotope brachytherapy, Chemoradiotherapy

PV-0139 Endorectal HDR brachytherapy boost with MRI guidance for non operative management of rectal cancer.

Authors: Engineer, R. Saklani, A. D'Souza, A. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS67-S68. 2p.

Subjects: High dose rate brachytherapy, Rectal cancer

Extra Mural Venous Invasion as an Independent Prognostic Marker in Locally Advanced Rectal Cancer: Propensity Score Match Pair Analysis.

Authors: Paul, D.S. Engineer, R. deSouza, A. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe592-e592. 1p.

Subjects: Propensity score matching, Rectal cancer, Institutional review boards

PO-1108: SCRT and chemotherapy vs LCRT for unresectable rectal cancers. A propensity matchedpair analysis.

Authors: Engineer, R. Saklani, A. D'souza, A. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS585-S585. 1p.

Subjects: Rectal cancer, Cancer chemotherapy

106P Efficacy and tolerability of capecitabine and mitomycin-C based concurrent radiotherapy in patients with anal canal cancer.

Authors: Bhargava, P.G. Engineer, R. Ramaswamy, A. et al.

Source: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1283-S1283. 1p.